Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

SEC Filings

This part of our website contains archival information which will not be considered current and may no longer be accurate.

Filing date	Form	Description	Filing Group	Downloads
10/02/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000095.rtf 0001100682-02-000095.pdf
09/25/02	8-K	Report of unscheduled material events or corporate event	Current Reports	0000912057-02-036832.rtf 0000912057-02-036832.pdf
09/20/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000085.rtf 0001100682-02-000085.pdf
09/06/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000083.rtf 0001100682-02-000083.pdf
09/05/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000079.rtf 0001100682-02-000079.pdf
09/04/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000067.rtf 0001100682-02-000067.pdf
09/04/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000070.rtf 0001100682-02-000070.pdf
09/04/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000072.rtf 0001100682-02-000072.pdf
09/04/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000075.rtf 0001100682-02-000075.pdf
09/04/02	4	Statement of changes in beneficial ownership of securities	3,4,5	0001100682-02-000077.rtf 0001100682-02-000077.pdf

Data provided by Kaleidoscope.

Featured Report

Charles River Corporate Citizenship Report
View PDF
Print PDF